Regulation, Compassionate Treatments, and Clinical Trials

In this episode of "How It Ticks," I sit down with Professor Dario Neri, the co-founder, CEO, and CSO of Philogen, to explore the multifaceted world of pharmaceutical research and development. Our conversation begins with Dario’s inspiring journey in academia, including what it was like working under Nobel Prize winners.

We then delve into the complexities of publishing medical research and discuss why, particularly in fields like COVID-19, there is so much conflicting information. Dario offers his insights on the pharmaceutical industry’s negative reputation and the challenges posed by varying regulatory bodies across different countries.

Next, we break down the different phases of drug trials, examining the types of participants involved and the rigorous processes required to bring a drug to market. Dario also shares his perspective on the pressure from shareholders to expedite drug approvals and how he navigates this as a CEO. Lastly, we discuss the landscape of cancer treatment companies and whether they are seen as competitors or allies in the fight against cancer.

Tune in to gain a comprehensive understanding of the journey from academic research to life-saving treatments and the critical issues facing the pharmaceutical industry today.